USPTO serial 79408867
Serial No. 79408867
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 30, 2025
- Examiner
- MILMOE, MAUREEN H
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Serial No. 79408867?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Minchul Yang
Minchul Yang STIP Law Group, LLC40 W. Chesapeake Ave, Suite 506Towson, MD 21204United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic reagents for scientific use; Reagents for scientific purposes for use in nucleic acid amplifications; Markers being reagents for scientific purposes for use in analyzing nucleic acid; Reagents for scientific purposes for use in extracting nucleic acid; Chemical reagents for use in nucleic acid amplifications, other than for medical or veterinary purposes; Chemical reagents for use in extracting nucleic acid, other than for medical or veterinary purposes; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Diagnostic reagents for scientific or research use; Reagents for scientific use | ACTIVE | — |
| 005 | Reagents for medical use; Drugs for medical purposes, namely, acetaminophen; Enzymes for medical purposes; Enzyme preparations for medical purposes; Nucleic acid sequences for medical and veterinary purposes; Diagnostic chemical preparations for medical purposes for use in DNA analysis; In vitro diagnostic preparations for medical purposes; Diagnostic test reagents for medical or veterinary purposes; Chemical reagents for medical or veterinary purposes; Reagents for use in medical genetic testing | ACTIVE | — |
| 009 | Diagnostic apparatus for research laboratory use for DNA analysis; Laboratory devices for DNA sequencing, not for medical purposes; Laboratory devices for analyzing polynucleic acid, not for medical purposes; Reagent containers being chips having multi-well arrays for use with protein analysis apparatus used in chemical analysis and biological analysis for laboratory research use; Laboratory devices for analyzing and extracting genes, not for medical purposes; Laboratory apparatus and instruments for preparing nucleic acid samples; Diagnostic chips being bio-chips for analyzing blood plasma for laboratory use; Laboratory apparatus, namely, devices for analyzing protein sequences, not for medical purposes; Scientific apparatus, namely, diagnostic apparatus for research laboratory use for analyzing genes | ACTIVE | — |
| 035 | Wholesale store services featuring chemicals for analyzing nucleic acid for scientific or laboratory purposes; Computerized database management; Retail store services featuring medical apparatus and instruments other than for dental purposes; Retail store services featuring chemicals for analyzing nucleic acid for scientific or laboratory purposes; Wholesale store services featuring pharmaceutical products for humans and animals; Retail store services featuring pharmaceutical products for humans and animals; Wholesale store services featuring chemical preparations for use in industry; Retail store services featuring chemical preparations for use in industry | ACTIVE | — |
| 042 | Biomarker discovery services being medical research; Medical diagnostic services using biomarker analysis; Selection and screening of biomarkers in biological tissue samples for scientific research purposes; Scientific research for medical purposes in the area of cancerous diseases; Consulting business, namely, consulting services in the field of biological sequence processing and analysis for medical research purposes; Research in the field of gene expression analysis; Development of computer software for use with medical equipment; Providing computer software technical support services, namely, troubleshooting of computer software problems in the field of medical diagnostics; Product development in the field of medical diagnostic devices; Blood testing business, namely, blood testing for medical research purposes | ACTIVE | — |
| 044 | Medical analysis for the diagnosis and treatment of persons; Medical laboratory analysis services relating to the treatment of persons; Medical services relating to the removal, treatment and processing of human blood; RNA or DNA analysis being medical analysis services for the diagnosis of cancer; Medical analysis services for the diagnosis of cancer; Providing information in the field of cancer prevention, screening, diagnosis and treatment; Provision of genetic testing for medical purposes; Provision of information for medical purposes in the field of gene therapy for cancer treatment; Medical diagnostic services; medical screening; Genetic counseling | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Meteor Biotech Co., Ltd.
- Other trademarks owned by Meteor Biotech Co., Ltd.
- Other trademarks owned by Meteor Biotech Co., Ltd.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 30, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 23, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 16, 2026 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Apr 9, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 9, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 6, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 6, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 30, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 30, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 30, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 12, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 12, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 6, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 5, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 5, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 5, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 5, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 5, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 1, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 1, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 1, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 17, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 2, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 2, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 14, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 13, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 10, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 8, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 8, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 7, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |